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Abstract. 
 
Many of the biochemical reactions of apop-
totic cell death, including mitochondrial cytochrome c
release and caspase activation, can be reconstituted in
 
cell-free extracts derived from 
 
Xenopus
 
 eggs. In addi-
tion, because caspase activation does not occur until the
egg extract has been incubated for several hours on the
bench, upstream signaling processes occurring before
full apoptosis are rendered accessible to biochemical
manipulation. We reported previously that the adaptor
protein Crk is required for apoptotic signaling in egg
extracts (Evans, E.K., W. Lu, S.L. Strum, B.J. Mayer,
and S. Kornbluth. 1997. 
 
EMBO (Eur. Mol. Biol. Or-
gan.) J.
 
 16:230–241). Moreover, we demonstrated that
removal of Crk Src homology (SH)2 or SH3 interactors
from the extracts prevented apoptosis. We now report
the ﬁnding that the relevant Crk SH2-interacting pro-
tein, important for apoptotic signaling in the extract, is
the well-known cell cycle regulator, Wee1. We have
demonstrated a speciﬁc interaction between tyrosine-
phosphorylated Wee1 and the Crk SH2 domain and
have shown that recombinant Wee1 can restore apopto-
sis to an extract depleted of SH2 interactors. Moreover,
exogenous Wee1 accelerated apoptosis in egg extracts,
and this acceleration was largely dependent on the
presence of endogenous Crk protein. As other Cdk in-
hibitors, such as roscovitine and Myt1, did not act like
Wee1 to accelerate apoptosis, we propose that Wee1–
Crk complexes signal in a novel apoptotic pathway,
which may be unrelated to Wee1’s role as a cell cycle
regulator.
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Introduction
 
The removal of harmful or unnecessary cells through apopto-
sis, or programmed cell death, is crucial to the health of mul-
ticellular organisms (for reviews see Vaux and Korsmeyer,
1999; Green, 2000). Apoptosis is important in a variety of
physiological contexts, including maintenance of the immune
system, embryological development, and organismal homeo-
stasis. Unlike necrosis, apoptotic cell death is compatible with
these biological processes as it allows removal of individual
cells without an accompanying inflammatory response. Dy-
ing cells are quickly destroyed, packaged into membrane-
bound vesicles, and phagocytosed by neighboring cells.
Although apoptotic signaling pathways differ between
cell types, in most cells the key executioners of the apop-
totic process are members of a protease family known as
the caspases (Alnemri, 1997). These proteases, which
share homology with the 
 
Caenorhabditis elegans
 
 death
gene product, CED-3, are synthesized in a zymogenic
form and activated either by proximity-induced autopro-
cessing or cleavage in trans by other caspases. Once acti-
vated, caspases undermine cellular integrity by cleaving
key cellular substrates such as nuclear lamins and gelsolin
(for review see Thornberry and Lazebnik, 1998).
In many apoptotic cells, caspase activation is preceded
by release of cytochrome c from the intermembrane space
of the mitochondria to the cytoplasm (for review see
Green and Reed, 1998). Once released into the cytosol, cy-
tochrome c serves as an activating cofactor in a multimeric
structure known as the “apoptosome,” comprised of a
caspase (caspase-9), an ATP-binding protein (Apaf-1),
and ATP (or dATP) (Liu et al., 1996; Li et al., 1997; Zou et
al., 1999). The apoptosome, once activated, induces pro-
teolytic activation of procaspase-9, which subsequently
cleaves and activates a workhorse of execution, caspase-3.
Hence, the mitochondrial release of cytochrome c is a par-
amount site of regulation of programmed cell death, in
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particular, by the Bcl-2 family of proteins (for review see
Gross et al., 1999). Proapoptotic members of the family,
such as Bax, promote the release of cytochrome c, while
antiapoptotic members, such as Bcl-xL, inhibit transloca-
tion of cytochrome c from the mitochondrial intermem-
brane space to the cytosol.
Apoptosis has been very well conserved in metazoans.
Not only are homologous apoptotic signaling molecules
conserved among flies, frogs, worms, and mammals, but
apoptotic regulators in one system can often functionally
substitute for those in another (e.g., Hengartner and Hor-
vitz, 1994; Newmeyer et al., 1994; Evans et al., 1997a; Ku-
wana et al., 1998; Dorstyn et al., 1999). In keeping with this
evolutionary conservation of the apoptotic program, the
dramatic biochemical and morphological events of apop-
tosis can be recapitulated in a cell-free system derived
from eggs of the frog, 
 
Xenopus laevis
 
 (Newmeyer et al.,
1994; Evans et al., 1997b; Kluck et al., 1997b). When these
extracts are incubated at room temperature, hallmark ap-
optotic activities, such as mitochondrial cytochrome c re-
lease, caspase activation, cleavage of apoptotic substrates,
and DNase activation can be observed. Furthermore, nu-
clei added to these extracts undergo morphological
changes characteristic of apoptosis, including chromatin
condensation, membrane vesiculation, and ultimately,
complete nuclear fragmentation. Although the physiologi-
cal basis for this apoptotic program has not been precisely
defined, it has been speculated that these extracts serve as
an in vitro model for oocyte atresia, wherein matured oo-
cytes that are not laid as eggs are reabsorbed by apoptotic
cell death (Hughes and Gorospe, 1991; Smith et al., 1991;
Tilly et al., 1992; Newmeyer et al., 1994).
Characterization of
 
 Xenopus
 
 egg extracts by several lab-
oratories has established that the egg extract displays ap-
propriate biochemical responses to common inhibitors of
apoptosis such as peptide inhibitors of caspases (ZVAD,
YVAD, DEVD, among others) and Bcl-2 (Newmeyer
et al., 1994; Kluck et al., 1997a,b). Additionally, previ-
ous work has demonstrated that this system is responsive
to proapoptotic signaling molecules such as 
 
Drosophila
 
Reaper and human caspase-8 (Evans et al., 1997a; Kuwana
et al., 1998). Moreover, it has been firmly established that
mitochondrial cytochrome c release is critical for apoptosis
in this system, as in other systems (Kluck et al., 1997a,b).
In analyzing the requirements for in vitro apoptosis in
this system, we and others have previously demonstrated
a role for phosphotyrosine signaling pathways in the early
events of apoptosis (Liu et al., 1994; Migita et al., 1994;
Evans et al., 1997b; Farschon et al., 1997). Building on
this, we found that the adaptor protein, Crk, is required
for the in vitro apoptosis in this system: immunodepletion
of Crk or addition of anti-Crk antisera, rendered the ex-
tracts unable to undergo apoptosis (Evans et al., 1997b).
Consistent with these results, we found that the isolated
Src homology (SH)
 
1
 
 2 domain of Crk, but not analogous
domains from other adaptor proteins, could inhibit apop-
tosis, presumably by acting as a dominant negative inhibi-
tor of endogenous Crk–phosphotyrosine signaling interac-
 
tions. Additionally, depleting extracts of Crk SH2-binding
proteins (using the glutathione 
 
S
 
-transferase [GST]–Crk
SH2 domain bound to glutathione-Sepharose) effectively
inhibited apoptosis (Evans et al., 1997b).
We report here the surprising finding that the relevant
Crk SH2 interacting protein, important for apoptotic sig-
naling in the extract, is the previously well-characterized
cell cycle regulator, Wee1 (Nurse and Thuriaux, 1980; Iga-
rashi et al., 1991; Parker et al., 1992; McGowan and Rus-
sell, 1993, 1995). Specifically, we have purified Wee1 as a
Crk SH2 interactor, demonstrated that Wee1 is required
for apoptosis in the extract, and shown that addition of ex-
ogenous Wee1 can markedly accelerate apoptosis. Al-
though Wee1 is best known as an inhibitor of the cell cycle
kinase, Cdc2, this activity does not seem to be responsible
for its apoptotic role, as other similarly potent Cdc2 inhib-
itors do not enhance apoptotic signaling. Perhaps most im-
portantly, we have found that Wee1’s role in apoptosis is
linked to Crk signaling. Addition of exogenous Wee1 re-
stored apoptosis to an extract depleted of Crk SH2 inter-
actors, and the ability of Wee1 to accelerate in vitro apop-
tosis was dependent on the presence of Crk. Collectively,
our data suggest that Wee1 and Crk cooperate in a novel
pathway of apoptosis in 
 
Xenopus
 
 egg extracts.
 
Materials and Methods
 
Protein Expression and Reagents
 
The expression of GST fused to Crk, the Crk SH2 domain, and the R38K
mutant of the Crk SH2 domain has been described previously (Evans et
al., 1997b). The baculovirus expression clones of GST-Myt1 and His-
tagged 
 
Xenopus
 
 Wee1 (XWee1) were kind gifts of Dr. Johannes Rudolph
(Department of Biochemistry, Duke University Medical Center) and Dr.
William G. Dunphy (Division of Biology, Howard Hughes Medical Insti-
tute, California Institute of Technology, Pasadena, CA), respectively. The
expression of Y-3 XWee1 (triple tyrosine mutant; Y90F, Y103F, and
Y110F) has been described previously (Murakami et al., 1999). The mono-
clonal Crk antibody was purchased from Transduction Laboratories. Poly-
clonal Crk antisera was a generous gift from Dr. Bruce J. Mayer (Depart-
ment of Genetics and Developmental Biology, University of Connecticut
Health Center, Farmington, CT). Preparation of the crude polyclonal
anti–XWee1 antisera has been described previously (Murakami and
Vande Woude, 1998). Additional affinity purified polyclonal anti-XWee1
antibody was purchased from Zymed Laboratories. Purified rabbit anti–
mouse IgG was purchased from Jackson ImmunoResearch Laboratories.
Antiphosphotyrosine antibody was purchased from Upstate Biotechnol-
ogy. Glutathione–Sepharose 4B was purchased from Amersham Pharma-
cia Biotech. Protein A–Sepharose 4B was purchased from Sigma-Aldrich.
 
Preparation of Xenopus Egg Extracts
 
For induction of egg laying, mature female frogs were injected with 100 U
of pregnant mare serum gonadotropin (Calbiochem) to induce maturation
of oocytes. Subsequently, 3–28 d later, a second injection of human chori-
onic gonadotropin (Upstate Biotechnology) was given to these frogs.
Within 12–20 h after human chorionic gonadotropin injection, eggs were
harvested for production of extracts. Jelly coats were removed using a 2%
cysteine solution (pH 8.0). Eggs were then washed three times using modi-
fied Ringer’s solution (MMR: 1 M NaCl, 20 mM KCl, 10 mM MgSO
 
4
 
, 25
mM CaCl 
 
2
 
, 5 mM Hepes, pH 7.8, 0.8 mM EDTA), and finally, washed
three times in egg lysis buffer (ELB: 250 mM sucrose, 2.5 mM MgCl
 
2
 
, 1.0
mM dithiothreitol, 50 mM KCl, 10 mM Hepes, pH 7.7). Eggs were packed
using low-speed centrifugation at 400 
 
g
 
, and subsequently cytochalasin B
(5 
 
m
 
g/ml, final concentration; Calbiochem), aprotinin/leupeptin (5 
 
m
 
g/ml,
final concentration), and cycloheximide (50 
 
m
 
g/ml, final concentration)
were added. Egg lysis was performed using centrifugation at 10,000 
 
g
 
 for 15
min. The crude extracts generated from this protocol were supplemented
with an energy regenerating system consisting of 2 mM ATP, 5 
 
m
 
g/ml cre-
 
1
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atine kinase, and 20 mM phosphocreatine (final concentrations). Recombi-
nant proteins added to these extracts were diluted into protein concentrat-
ing buffer (XB: 100 mM KCl, 0.1 mM CaCl
 
2
 
, 1 mM MgCl
 
2
 
, 10 mM KOH-
Hepes, pH 7.7, and 50 mM sucrose) at the indicated protein concentrations.
For visual apoptosis assays, nuclei were formed in extracts by addition
of demembranated sperm chromatin (
 
z
 
2,000 nuclei/
 
m
 
l). Extract samples
were taken at various time points during a room temperature incubation
and subjected to formaldehyde fixation and staining with Hoechst 33258.
Changes in nuclear morphology associated with apoptosis were monitored
using fluorescence microscopy.
To prepare purified cytosolic extracts, crude interphase extract was ul-
tracentrifuged at 200,000
 
 
 
g
 
 (70 min, 4
 
8
 
C) in a Beckman Coulter TL-100
centrifuge using a TLS 55 rotor. The cytosolic fraction was removed and
recentrifuged for an additional 25 min at 200,000
 
 
 
g
 
.
 
Purification of Crk SH2-binding Proteins
 
25 ml of crude egg extract was incubated with 5 ml of CNBr-activated
Sepharose 4B (Amersham Pharmacia Biotech) coupled to GST or GST–
Crk SH2 for 30 min at room temperature using the manufacturer’s proto-
col. The beads were pelleted and washed five times with ELB including 1
mM sodium vanadate and combined in a Bio-Rad Laboratories column.
The bound proteins were eluted from the resin with 10 ml (5 
 
3
 
 2 ml) boil-
ing SDS-PAGE buffer (62.5 mM Tris, pH 6.8, 2% SDS, 10% glycerol, and
0.7 M 
 
b-
 
mercaptoethanol). The eluate was loaded into dialysis tubing (8-kD
molecular mass cut off) and concentrated by placing Aquacide I (Calbio-
chem) around the dialysis tubing. When the eluate had been concentrated
to 200 
 
m
 
l, it was dialyzed against 62.5 mM Tris, pH 6.8, 0.7 M 
 
b
 
-mercapto-
ethanol overnight, supplemented with bromophenol blue, and loaded on a
long 7.5% SDS-PAGE gel. The gel was stained with Pro Blue Colloidol
Blue stain (Owl Separation Systems), and relevant protein bands were
subjected to peptide microsequencing (as described below).
 
Peptide Microsequencing
 
The bands of interest were excised from the one-dimensional gel and di-
gested in-gel with trypsin (Boehringer) in 10 mM Tris, pH 8.0, according to
the procedure of Shevchenko et al. (1996) except that alkylation of sulfhy-
dryls was accomplished with 4-vinylpyridine. After incubation at 37
 
8
 
C for
16 h, digests were vortexed and placed in a sonication bath for 5 min. The
liquid around the gel pieces was removed and saved. The gel pieces were
then extracted with a second aliquot of 10 mM Tris that was pooled with
the extracts. Finally, the gel pieces were extracted with acetonitrile, which
was combined with the other extracts. Volume and organic content in the
in-gel digest extract was reduced by concentration in a Speed Vac (
 
z
 
60 
 
m
 
l,
final volume). Proteolytic peptides from the in-gel digests were analyzed
using a fully automated nanoscale capillary liquid chromatography system
(Famos autoinjector/Ultimate chromatograph; LC Packings, Inc.) coupled
with a hybrid quadrupole/time-of-flight tandem mass spectrometer (Q-Tof;
Micromass, Inc.). 50-
 
m
 
l aliquots of the proteolytic peptides in 0.1% formic
acid–water were injected by the auto sampler onto a preconcentration/de-
salting column (300 
 
m
 
m inner diameter [ID] 
 
3
 
 1 mm long, 5 
 
m
 
m PepMap C
18; LC Packings, Inc.) at a flow rate of 25 
 
m
 
l/min. After desalting using a
mobile phase of 0.1% formic acid–water, the trapped peptides were back-
flushed onto a nanoscale capillary liquid chromatography (LC) column (75
 
m
 
m ID 
 
3 
 
15 cm long, 3 
 
m
 
m PepMap C 18; LC Packings, Inc.). A linear mo-
bile phase gradient at 200 nl/min of 2–32% acetonitrile in water (0.1% for-
mic acid in both buffers) over 30 min was used to elute the peptides into the
ion source (Z-Spray; Micromass, Inc.) of the mass spectrometer. The elec-
trospray was generated by connecting the LC eluant to nanoelectrospray
tips (360 
 
m
 
m outer diameter [OD], 20 
 
m
 
m ID, tapered down to 10 
 
m
 
m OD,
5 
 
m
 
m ID; New Objective, Inc.) which were distally coated with platinum. A
2,000 V potential was applied to the spraytips, giving a stable electrospray
across the LC gradient. Data-dependent scanning software (MassLynx; Mi-
cromass, Inc.) was used to acquire both molecular weight (MS spectra) and
amino acid sequence (production MS/MS spectra) information from the
peptides in chromatographic real time. Protein identifications from the
dataset were accomplished by using Mascot software (Matrix Sciences) to
search a nonredundant database, comparing the experimentally obtained
MS data (molecular weight) and MS/MS data (amino acid sequence) with
in-silico predictions from the nonredundant database.
 
DEVDase Assays
 
To monitor caspase activity, 3-
 
m
 
l aliquots of each extract sample at various
time points were incubated with 90 
 
m
 
l of DEVDase buffer (50 mM Hepes,
 
pH 7.5, 100 mM NaCl, 0.1% CHAPS, 10 mM DTT, 1 mM EDTA, 10%
glycerol) and the colorimetric peptide substrate Ac-DEVD-pNA (200
mM, final concentration) (BIOMOL Research Labs, Inc.). Enzyme reac-
tions were performed at 37
 
8
 
C for 30–60 min. The absorbance of the colori-
metric product was measured at 405 nm using a LabSystems MultiSkan
MS microtiter plate reader. As the samples for this assay were analyzed
spectrophotometrically, the density of pigment granules in the extracts
caused some variation in the background level of absorbance at 405 nm.
 
Crk and Wee1 Coimmunoprecipitation
 
Anti–c-Myc, HA, or Crk monoclonal antibody (2.5 
 
m
 
g antibody/sample)
was coupled to protein A– Sepharose beads (Sigma-Aldrich) for 1 h at 4
 
8
 
C
and washed in ELB twice. The antibody-coupled beads were blocked to
prevent nonspecific protein binding in ELB plus 10 mg/ml BSA for 20 min
at 4
 
8
 
C and washed twice with ELB. The isolated cytosolic extract was sup-
plemented with 1 mM sodium vanadate and an ATP-regeneration mix
and incubated at room temperature for 30 min. 20
 
 m
 
l of antibody-coupled
beads was added to 175 
 
m
 
l cytosolic extract and incubated for 1 h at 4
 
8
 
C.
The beads were then pelleted and washed four times with ELB containing
1 mM sodium vanadate. Proteins were eluted from beads by boiling in 2
 
3
 
sample buffer and run on a 7.5% SDS-PAGE gel. The gel was transferred
to membrane and probed with polyclonal antisera directed against the
XWee1 protein.
This same immunoprecipitation was also performed using affinity-puri-
fied polyclonal antisera directed against XWee1 (Zymed Laboratories)
coupled to protein A–Sepharose (as described above) or affinity-purified
rabbit IgG (Jackson ImmunoResearch Laboratories). Proteins eluted
from these beads were separated on a 10.5% SDS-PAGE gel and Western
blot analysis was performed using a polyclonal antibody directed against
Crk (Transduction Laboratories).
 
Immunodepletion and Antibody Addition Assays
 
Protein A–Sepharose resin (50-
 
m
 
l aliquots) (Sigma-Aldrich) was washed
two times with ELB and subsequently incubated with 1% BSA in ELB for
30 min at 4
 
8
 
C. This resin was then washed two additional times with ELB
and then incubated with 10 
 
m
 
g of anti-XWee1 IgG (Zymed Laboratories)
(control: 10 
 
m
 
g of rabbit IgG; Jackson ImmunoResearch Laboratories) or
50 
 
m
 
g total protein of polyclonal anti-Crk antiserum (control: 50 
 
m
 
g total
protein of preimmune serum) in a 1% BSA/ELB solution (total volume
400 
 
m
 
l). Protein A–IgG complexes were formed at 4
 
8
 
C for 1 h and then
washed two times in ELB. Egg extract samples (250 
 
m
 
l) were depleted
with the protein A–antibody resins (50 
 
m
 
l) two times for 30 min at 4
 
8
 
C.
Depleted extracts were supplemented with the energy-regenerating cock-
tail (described above), incubated at room temperature for 3–5 h, and sub-
jected to a DEVDase activity assay (as described above).
 
Crk SH2-binding Protein Pulldown Assays
 
The GST, Crk wild-type, Crk R38K SH2, or Crk SH2 recombinant pro-
teins were linked to glutathione-Sepharose beads. For pulldown assays
analyzed by Western blotting, 25 
 
m
 
l of beads was incubated with 200 
 
m
 
l
extract for 30 min at room temperature. The beads were then pelleted
and washed three to five times with ELB supplemented with 1 mM so-
dium vanadate to prevent tyrosine dephosphorylation. The bound pro-
teins were eluted in 2
 
3
 
 SDS sample buffer and separated on 7.5% SDS-
PAGE gel.
For determining effects of Crk SH2 domain on apoptotic activity, this
same technique was used. Extracts were depleted two times on the GST
protein resins under the conditions described above. The depleted ex-
tracts were then supplemented with the energy-regenerating mix de-
scribed above and incubated at room temperature for 3–5 h. Samples were
taken from these extracts at various time intervals and subjected to a
DEVDase assay (as described above).
 
Immunoblotting
 
Immunoblotting was performed after SDS-PAGE and transfer to poly-
vinylidene fluoride membranes (Millipore). Blots were incubated with
appropriate primary antisera described above and subsequently with
(secondary antibodies) horseradish peroxidase–linked goat anti–rabbit
antibody or goat anti–mouse antibody (Jackson ImmunoResearch Labo-
ratories). Blots were developed using an enhanced chemiluminescence
kit (Renaissance; Dupont). 
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Results
 
The Crk SH2 Domain Interacts Specifically with the 
Tyrosine Kinase Wee1 in Xenopus
Egg Extracts
 
As we had found that extracts depleted of Crk SH2 inter-
actors failed to undergo apoptosis, we wished to identify
Crk binding partners critical for transmission of the apop-
totic signal (Evans et al., 1997b). Accordingly, 
 
Xenopus
 
egg extracts were passed over a column of recombinant
GST–Crk SH2 domain cross-linked to CNBr-activated
Sepharose. SH2-bound proteins were eluted by boiling in
SDS-PAGE buffer, resolved by SDS-PAGE, and, since
SH2 domains function through binding phosphotyrosine
residues, immunoblotted with antiphosphotyrosine anti-
bodies. As shown in Fig. 1 A, only two tyrosine phos-
phorylated proteins from the egg extract were detected in
association with the Crk SH2 domain.
To identify the tyrosine phosphorylated proteins seen
binding to the SH2 domain, we scaled up the affinity chro-
matography procedure and analyzed the 68- and 97-kD ty-
rosine phosphorylated proteins by nanospray mass spec-
trometry. Surprisingly, the 68-kD binding protein was
unambiguously identified as XWee1. The 97-kD protein
was identified on the basis of 10 peptide sequences as vi-
tellogenin A2-precursor protein, a highly abundant pro-
tein involved in yolk formation of rapidly maturing oo-
cytes of oviparious species (vitellogenesis) (Wallace, 1985;
Gerber-Huber et al., 1987; Wahli, 1988). Although the 97-
kD protein contains potential consensus sites for Crk
binding, given its abundance and its previously suggested
role in vitellogenesis, we considered Wee1 a more likely
candidate for the relevant Crk-binding protein involved in
apoptotic signaling.
As shown in Fig. 1 B, the XWee1 sequence contains sev-
eral previously mapped tyrosine phosphorylation sites that
Figure 1. Purification of Crk
SH2 binding proteins. (A)
Crk SH2 binding proteins
were isolated as described in
Materials and Methods, re-
solved using SDS-PAGE,
and processed for Western
blot analysis using an an-
tiphosphotyrosine antibody.
Lane 1, GST beads plus ex-
tract; lane 2, GST–SH2 beads
plus ELB; lane 3, GST–SH2
beads plus extract. (B) Mi-
crosequencing analysis iden-
tified Wee1 as the specific
68-kD major Crk SH2 bind-
ing protein. Mass spectro-
metric analysis yielded two
peptides that match exactly
the sequence of the XWee1
protein. The first peptide,
IGAGEFGSVFK, corre-
sponds to amino acids 216–
226 in the Wee1 protein
sequence, and the second
peptide obtained from mi-
crosequencing, ANEILQEDY,
matches amino acids 395–403
(bold and underlined). Puta-
tive Crk SH2 binding consen-
sus sequences (YKTL, amino
acids 110–113; YSQL, amino
acids 403–406) are indicated
by bold text.
Figure 2. Wee1 binds to the Crk SH2 domain. (A) GST-fused Crk
SH2 domain linked to glutathione-Sepharose was used to precipi-
tate Crk SH2 binding proteins from egg extracts. GST bound to glu-
tathione-Sepharose resin was used as a control for nonspecific pro-
tein binding. Bead-bound material was washed in ELB to remove
nonspecific protein binding. Bound proteins were eluted in SDS-
PAGE sample buffer and detected by Western blot with polyclonal
anti-Wee1 antisera. (B) A mutant form of the Crk SH2 domain
(R38K), which does not bind tyrosine phosphoryalted proteins, does
not bind Wee1. Resins consisting of GST (lane 2), GST–SH2 (lane
4), or GST–-SH2R38K (lane 6) bound to glutathione-Sepharose
were incubated with Xenopus egg extract. The bead-bound material
was washed several times with ELB to remove nonspecific protein
binding and then resolved by SDS-PAGE. Wee1 binding was de-
tected by immunoblotting with an affinity-purified anti-XWee1 anti-
body. GST, GST–SH2, and GST–SH2R38K resins that were not in-
cubated with extract (lanes 1, 3, and 5, respectively) were also
resolved on this gel as negative controls. (C) Tyrosine phosphoryla-
tion of Wee1 is required for its interaction with Crk SH2 domain.
Lysates were generated from baculovirus-infected Sf9 cells express-
ing either wild-type (wt) XWee1 or a mutant form of XWee1 in
which three tyrosines (Y-3 Wee1; Y90, Y103, and Y110) were mu-
tated to phenylalanine. These lysates were incubated with either
GST (lanes 2 and 3) or GST–Crk SH2 domain (lanes 5 and 6) bound
to glutathione-Sepharose. Bead-bound material was washed several
times with ELB to remove nonspecific protein binding and subse-
quently resolved using SDS-PAGE. Western blot analysis, using an
affinity-purified polyclonal anti-XWee1 antibody, was used to deter-
mine whether XWee1 (lanes 2 and 5) or Y-3 Wee1 (lanes 3 and 6)
bound to either of the two resins. As negative controls, GST resin
(lane 1) and GST–Crk SH2 resin (lane 4), which were not incubated
with extract, were also resolved on this gel. 
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conform to the consensus for Crk SH2 binding (YXXP/L)
(Birge et al., 1993; Songyang et al., 1993). To confirm that
Wee1 could bind to the Crk SH2 domain, the population
of Crk-binding proteins was again resolved by SDS-PAGE
and examined by immunoblotting with anti-Wee1 sera. As
anticipated, the anti-XWee1 sera recognized a band of 68
kD in the GST–Crk pulldown, which was absent from con-
trol pulldowns with GST alone (Fig. 2 A). Consistent with
a role for tyrosine phosphorylation in mediating the SH2–
Wee1 interaction, a mutant form of the Crk SH2 domain
(R38K; Mayer and Hanafusa, 1990) unable to bind tyrosine
phosphorylated substrates was not able to bind Wee1 from
egg extracts (Fig. 2 B). In addition, the Crk SH2 domain
could not bind a variant of Wee1 mutated so as to change
tyrosine to phenylalanine at the known sites of Wee1 ty-
rosine phosphorylation (Fig. 2 C).
To demonstrate an interaction between endogenous
Crk and Wee1 proteins in the egg extract, Crk immuno-
precipitates were immunoblotted with polyclonal anti-
Wee1 sera. As shown in Fig. 3 A, an anti-Wee1 reactive
protein of 68 kD coprecipitated with the Crk monoclonal
antibody, but not with control monoclonal antibodies. In
the reciprocal experiment, a 34/36-kD doublet of Crk pro-
tein, detectable with an anti-Crk monoclonal antibody,
was found in anti-Wee1, but not control IgG immunopre-
cipitates (Fig. 3 B).
 
Wee1 Addition Accelerates Apoptosis in Xenopus
Egg Extracts
 
As our interest in identifying Crk-binding proteins was fo-
cused on proteins involved in apoptotic signaling, we
wished to determine whether Wee1 participated in the reg-
ulation of apoptosis in egg extracts. Hence, we produced
recombinant His-tagged XWee1 in baculovirus-infected
Sf9 cells for addition to egg extracts. As shown in Fig. 4 A,
addition of exogenous Wee1 produced a marked accelera-
tion of egg extract apoptosis, as measured by caspase acti-
vation (monitored spectrophotometrically using a model
Figure 3. Endogenous Crk and Wee1 physically interact in egg ex-
tracts. (A) Anti–c-Myc, HA, or Crk monoclonal antibodies were
bound to protein A–Sepharose and used to precipitate bound pro-
teins from egg extract as described in Materials and Methods.
Bead-bound material was washed in ELB to remove nonspecific
protein binding, and then resuspended in SDS-sample buffer and
processed for Western blotting using a polyclonal Wee1 antibody
for detection. (B) Reciprocal immunoprecipitation was performed
using a polyclonal Wee1 antibody or control IgG bound to protein
A–Sepharose. Samples were processed for Western blotting using
an anti-Crk monoclonal antibody for protein detection.
Figure 4. Addition of exogenous Wee1 accelerates apoptosis
in egg extracts. (A) His-tagged XWee1 produced in baculovi-
rus-infected Sf9 cells (20 or 10 ng/ml, final concentration) or
XB was added to egg extracts. During a room temperature in-
cubation, extract samples (3 ml) were taken at the indicated
times and processed for DEVD-pNA cleavage activity. (B)
His-tagged Wee1 (20 ng/ml, final concentration; right) or XB
(buffer control; left) was added at 1:10 (vol/vol) to extracts
supplemented with nuclei (z2,000 nuclei/ml). Extract samples
(2 ml) were taken at various time intervals, fixed with formal-
dehyde, and stained (chromatin) with Hoechst 33258. Fluores-
cence microscopy was used to visualize the nuclear morpho-
logical changes associated with apoptosis. (C) His-Wee1 (20
ng/ml, final concentration), purified cytochrome c (1.5 ng/ml,
final concentration), or XB was added to purified cytosolic egg
extracts lacking heavy membrane components, including mito-
chondria, at a 1:10 (vol/vol) dilution. During a room tempera-
ture incubation, extract samples were taken at the indicated
times and processed for DEVD-pNA cleavage activity. 
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caspase-3 substrate, DEVD-pNA). Other indicators of ap-
optotic progression were also accelerated by exogenous
Wee1: as shown in Fig. 4 B, addition of Wee1 (
 
z
 
10 ng/
 
m
 
l)
to extracts supplemented with nuclei promoted acceler-
ated membrane blebbing, chromatin condensation, and
nuclear fragmentation. As has been seen with other stimuli
that accelerate apoptosis in the egg extract, the caspase ac-
tivation and nuclear fragmentation were preceded by mi-
tochondrial cytochrome c release (data not shown). Con-
sistent with a requirement for mitochondrial cytochrome c
release, Wee1 could not promote caspase activation in pu-
rified cytosolic extracts lacking mitochondria (Fig. 4 C).
However, the addition of exogenous cytochrome c acti-
vated caspases in identical extracts, demonstrating their
apoptotic potential. While the absolute timing of sponta-
neous apoptosis varies from extract to extract, in all cases
recombinant Wee1 hastened the onset of apoptosis.
While these data appear to implicate Wee1 in apoptotic
regulation, the tyrosine kinase Wee1 has an already well-
defined role in the eukaryotic cell cycle: maintaining the
inactive state of Cdc2–cyclin complexes through phos-
phorylation of tyrosine 15 of Cdc2 (Coleman and Dunphy,
1994). This raised the possibility that Wee1 might acceler-
ate apoptosis by virtue of its ability to suppress cyclin-
dependent kinases in the extract. To address this issue, we
sought alternative means to suppress Cdk activity in the
extract. The dual specificity, membrane-associated kinase
Myt1 acts in concert with Wee1 to suppress Cdc2 through
phosphorylation of Tyr 15 and Thr 14 (Kornbluth et al.,
1994; Mueller et al., 1995). Recombinant baculovirus-pro-
duced Myt1, lacking its transmembrane domain, acts like
soluble Wee1 to inhibit Cdc2. By measuring phosphoryla-
tion of Cdc2–cyclin complexes in vitro, we were able to
calibrate our Wee1 and Myt1 preparations so as to obtain
equivalent amounts of Cdc2-phosphorylating activity in
each preparation (data not shown). Upon addition of each
of these preparations to egg extracts, we found that only
Wee1 was able to accelerate apoptosis; Myt1 had no such
 
effect (Fig. 5). In agreement with these results, we found
that treatment of extracts with the Cdk inhibitor rosco-
vitine was also unable to accelerate apoptotic progression
(data not shown). These data suggest that repression of
Cdk activity is unlikely to underlie the ability of Wee1 to
accelerate apoptosis in egg extracts.
 
Wee1 Is Required for Apoptotic Signaling in
Egg Extracts
 
Although the ability of exogenous Wee1 to accelerate ap-
optosis was consistent with a role for Wee1 in apoptotic
signaling, it was important to determine whether endoge-
nous Wee1 was required for apoptotic progression of the
native extract. As mentioned above, egg extracts incu-
bated at room temperature will, after a variable amount of
time (depending upon the particular extract), spontane-
ously activate caspases. Although the timing is variable
from extract to extract, it is highly consistent between ali-
quots of the same extract. Therefore, we were able to as-
sess the importance of Wee1 for egg extract apoptosis by
comparing caspase activation in aliquots of the same ex-
tract immunodepleted of Wee1. As shown in Fig. 6, A and
B, removal of endogenous Wee1 from egg extracts using a
protein A–Sepharose-linked, polyclonal anti-Wee1 anti-
body caused a significant delay in the kinetics of caspase
activation compared with control IgG-depleted extracts.
Similarly, the direct addition of Wee1 antibody to the ex-
tract (50 ng IgG/
 
m
 
l of extract) inhibited DEVDase activa-
tion, whereas control IgG added to extracts at identical
concentrations had negligible effects on caspase activation
(Fig. 6 C). Furthermore, addition of recombinant Wee1, at
concentrations approximating that of endogenous Wee1,
could restore caspase activation to extracts treated with
anti-Wee1 IgG (Fig. 6 D).
The ability of Wee1 immunodepletion and/or antibody
inhibition to strikingly dampen caspase activation was
consistent with our hypothesis that removal of Wee1 in as-
sociation with the Crk SH2 domain was responsible for the
apoptotic inhibition that followed depletion of extracts us-
ing the GST–Crk resin. Similarly, the ability of free GST–
SH2 protein to inhibit apoptosis in the extract presumably
resulted from interference with endogenous Wee1–Crk in-
teractions. To prove this more rigorously, we added excess
recombinant Wee1 to extracts depleted of GST–SH2 bind-
ing partners. As shown in Fig. 7, apoptotic progression, as
measured by caspase activation, was restored by addition
of Wee1 to the SH2-depleted extracts. In aggregate, these
data strongly suggest that Wee1 participates in apoptotic
signal transduction in 
 
Xenopus
 
 egg extracts.
 
Wee1 Signals in a Crk-mediated Apoptotic Pathway
 
To distinguish whether Wee1-mediated acceleration of ap-
optosis occurred through Crk or a parallel pathway, we
added exogenous Wee1 to extracts immunodepleted of
endogenous Crk using Crk antisera bound to protein
A–Sepharose. As shown in Fig. 8, Wee1 was considerably
more effective at accelerating caspase activation in the
presence of endogenous Crk protein. These data suggest
either that Crk acts downstream of Wee1 in promoting ap-
optosis or that Crk and Wee1 must act in concert to signal
in apoptotic pathways. As Crk only weakly stimulates ap-
Figure 5. Wee1, but not Myt1, accelerates caspase activation in
egg extracts. Recombinant GST–Myt1 and His-Wee1 were di-
luted into XB such that the amount of Cdc2-phosphorylating ac-
tivity of each preparation was equal. These kinases, normalized
for activity, were then added to egg extracts at a 1:10 dilution
(vol/vol). These treated extracts were incubated at room temper-
ature and subjected to a DEVDase assay with extract samples
taken at the indicated times. 
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optosis upon overproduction in egg extracts (Evans et al.,
1997b; Smith, J.J., and S. Kornbluth, unpublished results),
it may be that binding of Wee1, which would not be in suf-
ficient excess to interact with the majority of the exoge-
nously added Crk, is required in some way to enhance the
intrinsic apoptotic activity of Crk.
 
Discussion
 
Although cell-free extracts derived from cultured cells
have been instrumental in isolating many core components
of the apoptotic machinery (e.g., Apaf-1, cytochrome c,
caspase-9; Duan et al., 1996; Liu et al., 1996; Zou et al.,
1997), 
 
Xenopus
 
 egg extracts offer a thus far unique oppor-
tunity to examine the early signaling events of apoptosis in
a biochemically accessible, synchronous system. In this re-
port, we have used this system to examine apoptotic signal-
ing by the Crk adaptor protein and have identified the
well-known cell cycle regulator Wee1 as a component of a
Crk-mediated apoptotic signaling pathway.
 
Figure 6
 
. Endogenous Wee1 is required for apoptosis in egg ex-
tracts. (A) Egg extracts were depleted of endogenous Wee1 using
affinity-purified polyclonal anti-Wee1 IgG; or mock depleted us-
ing purified rabbit IgG (control) bound to protein A–Sepharose
(two consecutive depletions; 4
 
8
 
C, 30 min). Depleted extracts were
incubated at room temperature and subjected to a DEVDase ac-
tivity assay with extract samples taken at the indicated times. (B)
Depletion of endogenous Wee1 was confirmed by Western blot
analysis of (2 
 
m
 
l) samples of depleted extracts using the polyclonal
Wee1 antibody for protein detection. The numbers 1 and 2 repre-
sent the first or second rounds of depletion, respectively. (C) The
affinity-purified polyclonal anti-Wee1 IgG or control IgG was
added (50 ng IgG/
 
m
 
l extract) at a 1:10 (vol/vol) dilution. These ex-
tracts were supplemented with energy-regenerating cocktail, incu-
bated at room temperature, and subjected to a DEVDase activity
assay with extract samples taken at the indicated times. (D) Affin-
ity-purified anti-XWee1 IgG or control rabbit IgG was added to
egg extracts (final concentration 20 ng/ml). Recombinant Wee1
(final protein concentration 20 ng/ml) or XB was added to the ex-
tracts at 1:10 (vol/vol) dilution. These extracts were subsequently
treated with an energy-regenerating cocktail and incubated at
room temperature. Extract samples (3 ml) were taken at the indi-
cated times and subjected to a DEVDase assay.
Figure 7. Wee1 restores apoptotic activity to Crk SH2–depleted
extracts. GST–Crk SH2 domain bound to glutathione-Sepharose
was used to deplete egg extracts (two times, 30 min, 48C). Re-
combinant Wee1 (20 ng/ml, final concentration) or XB (control)
was added to depleted extracts at a 1:10 dilution (vol/vol). The
depleted extracts were also supplemented with energy-regenerat-
ing cocktail, incubated at room temperature. Samples were taken
at the indicated times and subjected to a DEVDase assay.The Journal of Cell Biology, Volume 151, 2000 1398
Wee1 Regulates Apoptosis in Xenopus Egg Extracts
For each batch of Xenopus egg extract, there is a charac-
teristic time that elapses before that extract enters apopto-
sis. Using many different extracts, we found that addition
of exogenous recombinant Wee1 consistently and repro-
ducibly accelerated the initiation of apoptosis, as mea-
sured by mitochondrial cytochrome c release, caspase acti-
vation, and nuclear fragmentation. Consistent with a role
for Wee1 in modulating the in vitro apoptosis in Xenopus
egg extracts, neutralization of Wee1 function through ei-
ther antibody addition or immunodepletion severely de-
layed the onset of apoptosis.
Although incubation of egg extracts at room tempera-
ture leads to activation of the apoptotic program, the origin
of the apoptotic signal in this system is unknown. The abil-
ity of these extracts to undergo apoptosis has been specu-
lated to reflect the in vivo process of oocyte atresia,
wherein oocytes that do not receive the appropriate trophic
support die by apoptosis (Hughes and Gorospe, 1991;
Smith et al., 1991; Tilly et al., 1992; Newmeyer et al., 1994).
An alternative hypothesis is based on the observation that
inhibition of zygotic transcription/translation usually initi-
ated at the midblastula transition (MBT) results in massive
apoptosis of embryos at the early gastrula transition.
(Hensey and Gautier, 1997; Sible et al., 1997; Stack and
Newport, 1997). The available data on this phenomenon
are consistent with the presence of a maternal apoptotic in-
hibitor that is degraded over time and must be replaced by
synthesis of new (or more) zygotic inhibitors at the MBT to
prevent apoptosis when the maternal inhibitor is depleted
at the early gastrula transition. It is possible that a maternal
apoptotic program is unmasked when maternally encoded
inhibitors of apoptosis are degraded or otherwise inacti-
vated by incubation of egg extract on the bench.
In  Xenopus, Wee1 is present during early oogenesis
(stages I–IV), is absent from stage VI oocytes, reappears
at meiosis II, and persists throughout gastrulation (Mu-
rakami and Vande Woude, 1998; Nakajo et al., 2000).
Therefore, if Wee1 participates in an in vivo process of oo-
cyte atresia, it might do so early in oogenesis. Perhaps
more plausibly, the amount of Wee1 translated as oocytes
transit to maturation might determine the propensity of
the mature oocyte/egg to undergo apoptosis before laying
and fertilization. Indeed, preliminary data suggest that ex-
tracts prepared from stage VI oocytes, lacking Wee1, are
refractory to apoptosis in vitro (Evans, E.K., and S. Korn-
bluth, unpublished results).
Although Wee1 plays a preeminent role in regulating en-
try into mitosis, this function of Wee1 reflects its ability to
suppress cyclin-dependent kinases (Parker et al., 1992;
McGowan and Russell, 1993; Coleman and Dunphy, 1994;
Murakami and Vande Woude, 1998; Murakami et al., 1999;
Nakajo et al., 2000; Walter et al., 2000). The role of Cdc2
and its close relative, Cdk2, in modulating apoptosis has
been somewhat controversial. Although discrepancies may
legitimately be ascribed to cell type differences, active Cdc2
or Cdk2 has been variously reported either to accelerate ap-
optosis, inhibit apoptosis, be required for apoptosis, or be
entirely dispensable for apoptosis (Meikrantz et al., 1994;
Norbury et al., 1994; Chen et al., 1995; Ongkeko et al., 1995;
Meikrantz and Schlegel, 1996; Yao et al., 1996; Zhou et al.,
1998). As suppression of Cdc2 by either Myt1 or roscovitine
had no effect on the rate of apoptotic progression in our ex-
tracts, we consider it unlikely that simple suppression of
Cdc2/Cdk2 activities underlies the ability of Wee1 to accel-
erate apoptosis. Although ectopic expression of Myt1 in oo-
cytes was reportedly unable to function like Wee1 in sup-
pressing germinal vesicle breakdown, in that case the
authors suspected that Myt1 was only weakly active either
due to expression levels or progesterone-induced down reg-
ulation (Nakajo et al., 2000). In our experiments, Wee1 and
Myt1 preparations were added exogenously, obviating ex-
pression problems, after calibration for equivalent levels of
Cdc2–cyclin B-phosphorylating activity; roscovitine concen-
trations used were also shown to be entirely effective in sup-
pressing cyclin B–induced activation of histone H1–directed
kinase activity (data not shown). Therefore, these experi-
ments point to an alternative mode of action for Wee1. It is
possible that Wee1 does double duty as a cell cycle regula-
tor and an apoptotic regulator, ideally situating it as a piv-
otal participant in the decision to proceed to fertilization
and embryogenesis or to enter apoptosis.
Wee1 Interacts with a Crk-dependent Apoptotic 
Signaling Pathway
Previous work aimed at elucidating a pathway of apoptotic
signaling in Xenopus egg extracts implicated the adaptor
protein Crk and proteins interacting with its SH2 and
NH2-terminal SH3 domains (Evans et al., 1997b). Al-
though Wee1 is not a particularly abundant protein in Xe-
nopus egg extracts, in affinity chromatography experi-
ments it emerged as a prominent binding partner of the
isolated Crk SH2 domain. Moreover, the ability of exoge-
nous Wee1 to accelerate apoptosis depended on the pres-
ence of Crk in the extract.
As the name “adaptor” implies, Crk and proteins like it
are believed to function in the physical joining, or colocal-
Figure 8. Wee1 signals on a Crk-mediated apoptotic pathway.
Egg extracts were depleted with immune complexes formed from
polyclonal anti-Crk antisera or preimmune sera bound to protein
A–Sepharose (two consecutive depletions; 48C, 30 min). Recom-
binant His-tagged Wee1 (10 ng/ml, final concentration) or XB
(control) was added to the depleted extracts at a 1:10 dilution
(vol/vol). Extracts were incubated at room temperature, and ex-
tract samples were taken at the indicated times in order to assay
DEVD-pNA cleavage activity.Smith et al. Crk and Wee1 in Xenopus Apoptosis 1399
ization, of distinct classes of molecules, in this case tyrosine
phosphorylated SH2 binders and polyproline-containing
SH3 interactors (Birge et al., 1996). Most commonly, a
membrane-bound tyrosine kinase receptor autophosphor-
ylates after ligand engagement, providing a membrane
docking site for an adaptor protein, thereby coconcentrat-
ing SH3-bound ligands at the membrane. However, in the
case of Wee1–Crk, it would seem that a predominantly nu-
clear protein, Wee1, interacts with Crk to signal apoptosis.
Although Crk has been reported to localize predominantly
to focal adhesions in intact cells, we and others have also
observed a substantial proportion of Crk in the nucleus of
cultured cells, both by immunofluorescence and GFP tag-
ging (Matsuda et al., 1993; Smith, J.J., and S. Kornbluth,
unpublished results). Moreover, fluorescein-tagged recom-
binant Crk concentrates in nuclei in the egg extract (Evans,
E.K., and S. Kornbluth, unpublished results). Therefore, it
is entirely possible that Crk–Wee1 is part of a proapoptotic
signal emanating from the nucleus.
In Xenopus egg extracts, intact nuclei only form upon ad-
dition of exogenous chromatin or nuclei. However, even in
the absence of added nuclei, light membranes present in the
extract form sheets of annulate lamellae containing nuclear
pore complexes which are competent to transport macro-
molecules; hence, even an extract entirely lacking nuclei
contains structures which may accumulate normally nuclear
proteins. Interestingly, the basal rate of caspase activation
in extracts containing added nuclei substantially exceeded
that in extracts lacking nuclei (Smith, J.J., and S. Kornbluth,
unpublished results), and Wee1 further accelerated apopto-
sis in nuclei-containing extracts (data not shown).
An alternative model for Wee1–Crk function, indepen-
dent of nuclear compartmentalization, is that Crk func-
tions to bring Wee1 in close contact with a Crk SH3 binder;
conversely, Wee1 might function to juxtapose Crk and one
of its (non-Crk) binding partners. We have found that de-
pletion of Crk SH3 interactors from egg extracts (using a
GST–Crk SH3 column) inhibits Wee1-induced accelera-
tion of apoptosis, further implicating downstream Crk-
mediated signaling pathways in Wee1-dependent apop-
totic pathways (Smith, J.J., and S. Kornbluth, unpublished
results). Interestingly, Coomassie blue staining of GST–
Crk SH2 interactors (run in parallel with the antiphospho-
tyrosine Western blot shown in Fig. 1) revealed approxi-
mately seven specific proteins associated with the SH2
precipitates (data not shown). This suggests the possibility
that Crk–Wee1 may be part of a larger multiprotein com-
plex. However, apart from Wee1, none of the Coomassie
blue–stainable proteins were quantitatively depleted from
the extract in association with the GST–SH2 resin (Evans,
E.K., and S. Kornbluth, unpublished results). Distinguish-
ing between the various models of Crk–Wee1 function will
require identification of Crk SH3 ligands, or potentially
other Wee1 ligands, which are required for apoptosis. In-
terestingly, if any of these mechanisms are relevant to very
early embryonic development in Xenopus, they must be
engaged in the beginning of the first embryonic cell cycle,
since tyrosine phosphorylation of Wee1, upon which Crk
binding depends, disappears after the first cell cycle until
after the MBT (Murakami et al., 1999). Alternatively,
Wee1 tyrosine phosphorylation may be permissive for en-
gagement of the apoptotic machinery after the MBT.
Crk–Wee1 and Mammalian Cell Apoptosis
Inevitably, the question arises as to whether the Wee1–
Crk complex participates in an apoptotic process unique
to Xenopus oocytes/eggs/embryos or whether this complex
might play a role in mammalian somatic cell apoptosis.
While we and others have observed that overexpression of
Crk can accelerate apoptosis in intact human tissue culture
cells, it is not yet clear if this is a Wee1-regulated event
(Parrizas et al., 1997; Smith, J.J., and S. Kornbluth, unpub-
lished results). However, it is attractive to speculate that
genotoxic damage might trigger either a Wee1-dependent,
checkpoint-mediated cell cycle arrest or a Wee1-regulated
apoptotic pathway, depending on the degree of DNA
damage. In addition, cell cycle–regulated inhibition of
Wee1–Crk complexes may help to prevent the onset of ap-
optosis when cells are detached from their neighbors and
the substratum at the time of entry into mitosis. During in-
terphase, cells that do not have proper matrix or cell–cell
interactions will initiate an apoptotic program coined
“anoikis” (Frisch and Francis, 1994; Frisch et al., 1996).
However, this program is not initiated at each mitosis, de-
spite the fact that cells round up and lose physical contact
with both the extracellular matrix and surrounding cells.
Wee1 tyrosine phosphorylation, thought to result from au-
tophosphorylation, is likely absent at mitosis when Wee1
is inactive, thereby preventing binding of Crk and en-
gagement of a Wee1–Crk apoptotic pathway. These and
other possibilities await future examination of mammalian
Wee1, Crk, and potential Wee1–Crk complexes in apop-
totic regulation.
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